new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)


H Lee Moffitt Cancer Center And Research Institute Inc patents

Recent patent applications related to H Lee Moffitt Cancer Center And Research Institute Inc. H Lee Moffitt Cancer Center And Research Institute Inc is listed as an Agent/Assignee. Note: H Lee Moffitt Cancer Center And Research Institute Inc may have other listings under different names/spellings. We're not affiliated with H Lee Moffitt Cancer Center And Research Institute Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "H" | H Lee Moffitt Cancer Center And Research Institute Inc-related inventors

Date H Lee Moffitt Cancer Center And Research Institute Inc patents (updated weekly) - BOOKMARK this page
04/13/17Gamma-aa-peptide stat3/dna inhibitors and methods of use
03/23/17Tumor-infiltrating lymphocytes for adoptive cell therapy
03/16/17Radiologically identified tumor habitats
03/09/17Evidence-based clinical decision system
03/02/17Histone deacetylase 6 inhibition for enhancing t-cell function during anti-tumor response and tumor-peptide vaccination
03/02/17Bispecific antibody for cancer immunotherapy
02/23/17Histone deacetylase as a modulator of pdl1 expression and activity
02/23/17Inhibitors of rho associated protein kinases (rock) and methods of use
02/23/17Marinopyrrole derivatives and methods of making and using same
02/16/17Icariin derivatives
02/16/17Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy
02/09/17Selective histone deactylase 6 inhibitors
02/02/17Thiosemicarbazones inhibitors of lysophosphatidic acid acyltransferase and uses thereof
02/02/17Determining prostate cancer recurrence using polymorphisms in angiogenesis-related genes
01/26/17Microrna assay for detection and management of pancreatic cancer precursors
01/05/17Aurora kinase inhibitors and methods of making and using thereof
01/05/17Microrna signature for predicting progression of barrett's esophagus
12/22/16Personalized myeloma detection
12/22/16Personalized myeloma detection
12/15/16Methods and systems for performing segmentation and registration of images using neutrosophic similarity scores
11/24/16Methods and materials for monitoring myeloma using quantitative mass spectrometry
11/10/16Immune gene signatures in cancer
10/27/16Pathology case review, analysis and prediction
10/20/16Locking brakes for enteral feeding tube retention member
09/08/16Integrin interaction inhibitors for the treatment of cancer
09/08/16Method for selecting cancer treatment regimen
09/08/16Systems and methods for diagnosing tumors in a subject by performing a quantitative analysis of texture-based features of a tumor object in a radiological image
09/01/16Integrated virtual patient framework
08/11/16Cyclic peptide conjugates and methods of use
07/28/16Soluble cd33 for treating myelodysplastic syndromes (mds)
07/21/16Orogastric tube guide
07/21/16Colorectal cancer recurrence gene expression signature
07/14/16Compositions and methods for treating anaplastic thyroid cancer
07/14/16Systems, methods and devices for analyzing quantitative information obtained from radiological images
06/30/16Selective histone deactylase 6 inhibitors
06/23/16Inhibitors of ack1/tnk2 tyrosine kinase
05/19/16Platinum compounds that inhibit constitutive stat3 signaling and induce cell cycle arrest and apoptosis of malignant cells
04/28/16Breast imaging reporting and data system (bi-rads) tissue composition
04/21/16Automated percentage of breast density measurements for full field digital mammography
03/24/16Inhibitors of the ire-1/xbp-1 pathway and methods of using thereof
02/25/16Molecular imaging probes for lung cancer intraoperative guidance
12/31/15Biomarkers and methods for predicting benefit of adjuvant chemotherapy
12/24/15Symmetrical marinopyrrole derivatives as potential antibiotic agents
12/17/15Super lewis acidic borate esters as 18f-labeled pet probes
12/10/15Heat shock protein (hsp) inhibition and monitoring effectiveness thereof
12/10/15Quantitative predictors of tumor severity
12/03/15Targeted sensitization of non-del(5q) malignant cells
12/03/15Rnf41 as a biomarker predicting response to lenalidomide in non-del(5q) mds
10/22/15In silico identification of cancer molecular signaling pathways and drug candidates
10/01/15Cd28 expression during lenalidomide immune modulation
09/24/15Methods of treating cognitive impairment
09/17/15Stat3 dimerization inhibitors
09/10/15Method of cancer diagnosis, progression and response to therapy using a primary xenograft mouse model for cancer serum biomarker discovery
07/16/15Multi-spectral fluorescence for in-vivo determination of proton energy and range in proton therapy
06/04/15Methods and apparatuses using molecular fingerprints to provide targeted therapeutic strategies
05/21/15Method of diagnosing, treating and determining progression and survival of cancer cells using bcl-2 antagonist of cell death (bad) pathway gene signature
05/07/15Determining prostate cancer recurrence using polymorphisms in angiogenesis-related genes
04/30/15Predictive biomarkers for ctla-4 blockade therapy and for pd-1 blockade therapy
04/16/15Peptoid-peptide hybrids and their use
04/02/15Vascular anastomosis stent
03/19/15O-glycan pathway ovarian cancer signature
03/19/15Marinopyrrole derivatives as anticancer agents
03/12/15Peptides for the treatment of cancer
02/12/15Materials and methods for differential treatment of cancer
01/15/15Integrin interaction inhibitors for the treatment of cancer
Patent Packs
01/08/15Endotracheal tubes and evaluating breathing
01/01/15Histology recognition to automatically score and quantify cancer grades and individual user digital whole histological imaging device
01/01/15Telomerase reverse transcriptase deficiency as diagnostic marker of myelodysplastic syndrome
07/10/14Methods and diagnosis and/or prognosis of cancer
06/26/14Novel rho kinase inhibitors and methods of use
05/15/14Histology slide and paraffin block system
04/24/14Orogastric tube guides and methods of using the same
04/24/14Method of developing a vaccine using peptide-poly ic complexes
04/17/14Method of screening for colon cancer using biomarkers
03/13/14Proteasome chymotrypsin-like inhibition using pi-1833 analogs
02/27/14Aurora kinase inhibitors and methods of making and using thereof
02/13/14Ack1 kinase inhibition to treat triple negative breast cancer
02/13/14Animal model of human cancer and methods of use
01/16/14Bad phosphorylation determines ovarian cancer chemo-sensitivity and patient survival
01/02/14Multi-segmented inflatable brachytherapy devices, systems, and methods of using the same
Patent Packs
12/26/13Compositions and methods apc, creb, and bad pathways to assess and affect cancer
12/26/13High flow rate isolated infusion for regional treatment of cancer and medical conditions
11/14/13Catheter clamps and catheters
11/14/13Disposable venous tourniquets and methods of use
10/17/13Method for assessing breast density
10/03/13Methods and materials for monitoring myeloma using quantitative mass spectrometry
09/26/13Chemokine gene-modified cells for cancer immunotherapy
09/26/13Method of diagnosing early stage non-small cell lung cancer
07/25/13Dual inhibitors of farnesyltransferase and geranylgeranyltransferase i
07/04/13Hybrid model for the classification of carcinoma subtypes
05/23/13Molecular imaging of cancer cells in vivo
03/07/13Pyridylthiazole-based ureas as inhibitors of rho associated protein kinase (rock) and methods of use
02/07/13Immune gene signatures in cancer
12/20/12Methods of predicting high grade gliomas using senescence associated genes
12/13/12Method of identifying myelodysplastic syndromes
11/01/12Method of increasing intratumoral phe and reducing acid-mediated invasion
10/11/12Histology slide and paraffin block protector and transport sleeve
06/21/12Ct atlas of musculoskeletal anatomy to guide treatment of sarcoma
03/22/12Ct atlas of the brisbane 2000 system of liver anatomy for radiation oncologists
03/01/12Hep-lock and iv site dry mitt
03/01/12Akt tyrosine 176 phosphorylation cancer biomarker
02/09/12Methods for inducing tumor regression, inhibiting tumor growth, and inducing apoptosis in breast tumors with geranylgeranyltransferase i inhibitors
11/24/11Computer selecting subjects for clinical trials
11/10/11Nuclear export inhibitors of topoisomerase ii alpha
11/10/11Value network
03/03/11Small molecule e2f inhibitor

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with H Lee Moffitt Cancer Center And Research Institute Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for H Lee Moffitt Cancer Center And Research Institute Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by